Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ter Arkh ; 94(1): 32-47, 2022 Jan 15.
Artigo em Russo | MEDLINE | ID: mdl-36286918

RESUMO

AIM: Study the impact of various combinations of comorbid original diseases in patients infected with COVID-19 later on the disease progression and outcomes of the new coronavirus infection. MATERIALS AND METHODS: The ACTIV registry was created on the Eurasian Association of Therapists initiative. 5,808 patients have been included in the registry: men and women with COVID-19 treated at hospital or at home. CLINICALTRIALS: gov ID NCT04492384. RESULTS: Most patients with COVID-19 have original comorbid diseases (oCDs). Polymorbidity assessed by way of simple counting of oCDs is an independent factor in negative outcomes of COVID-19. Search for most frequent combinations of 2, 3 and 4 oCDs has revealed absolute domination of cardiovascular diseases (all possible variants). The most unfavorable combination of 2 oCDs includes atrial hypertension (AH) and chronic heart failure (CHF). The most unfavorable combination of 3 oCDs includes AH, coronary heart disease (CHD) and CHF; the worst combination of 4 oCDs includes AH, CHD, CHF and diabetes mellitus. Such combinations increased the risk of lethal outcomes 3.963, 4.082 and 4.215 times respectively. CONCLUSION: Polymorbidity determined by way of simple counting of diseases may be estimated as a factor in the lethal outcome risk in the acute phase of COVID-19 in real practice. Most frequent combinations of 2, 3 and 4 diseases in patients with COVID-19 primarily include cardiovascular diseases (AH, CHD and CHF), diabetes mellitus and obesity. Combinations of such diseases increase the COVID-19 lethal outcome risk.


Assuntos
COVID-19 , Doenças Cardiovasculares , Doença das Coronárias , Diabetes Mellitus , Insuficiência Cardíaca , Hipertensão , Doenças não Transmissíveis , Adulto , Feminino , Humanos , Masculino , Doenças Cardiovasculares/diagnóstico , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/etiologia , Doença Crônica , COVID-19/diagnóstico , COVID-19/epidemiologia , Hipertensão/diagnóstico , Hipertensão/epidemiologia , Prognóstico , Sistema de Registros , SARS-CoV-2
2.
Ter Arkh ; 92(11): 57-61, 2020 Dec 26.
Artigo em Russo | MEDLINE | ID: mdl-33720605

RESUMO

Despite the significant achievements and successes of medical science, the incidence of influenza, its complications and socio-economic damage do not decrease, remaining at a high level. In the clinic of Mechnikov North-Western State Medical University from December 2018 to February 2019, from 89 hospitalized patients with pneumonia/acute bronchitis viral etiology was determined in 29 (32%). In 27 (97%) patients it was virus A (H1N1), in 2 cases A (H3N2). 9 (31%) patients were sever and were hospitalized in intensive care unit. The case of severe viral pneumonia caused by A (H3N2) complicated by fulminant pulmonary hemorrhage with a lethal outcome is presented.


Assuntos
Vírus da Influenza A Subtipo H1N1 , Influenza Humana , Pneumonia Bacteriana , Pneumonia Viral , Síndrome do Desconforto Respiratório , Hemorragia/etiologia , Humanos , Vírus da Influenza A Subtipo H3N2 , Influenza Humana/complicações , Pneumonia Viral/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...